A Physicians' Wish List for the Clinical Application of Intestinal Metagenomics

PLoS Medicine

Volumn 11, Issue 4, 2014, Pages

  Klymiuk, Ingeborg ^a   Högenauer, Christoph ^a   Halwachs, Bettina ^b,c   Thallinger, Gerhard G ^b,c   Fricke, W Florian ^d   Steininger, Christoph ^e  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^c AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PROBIOTIC AGENT; RNA 16S;

ALGORITHM; ARTICLE; AUTOIMMUNE DISEASE; BIOPSY; ENDOSCOPY; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINAL METAGENOMICS; INTESTINE FLORA; METABOLIC DISORDER; METAGENOMICS; MICROFLORA; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRACTICE GUIDELINE; INTESTINE; MICROBIOLOGY;

HUMANS; INTESTINES; METAGENOMICS; MICROBIOTA;

EID: 84900387954     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001627     Document Type: Article

References (36)

1. Human Microbiome Project Consortium (2012) A framework for human microbiome research. Nature 486: 215-221.
2. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. (2007) The human microbiome project. Nature 449: 804-810.
3. Sellitto M, Bai G, Serena G, Fricke WF, Sturgeon C, et al. (2012) Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS ONE 7: e33387.
4. Sjoberg V, Sandstrom O, Hedberg M, Hammarstrom S, Hernell O, et al. (2013) Intestinal T-cell responses in celiac disease-impact of celiac disease associated bacteria. PLoS ONE 8: e53414.
5. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179-185.
6. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, et al. (2011) Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6: e16393.
7. Lin XB, Dieleman LA, Ketabi A, Bibova I, Sawyer MB, et al. (2012) Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS ONE 7: e39764.
8. Loman NJ, Constantinidou C, Christner M, Rohde H, Chan JZ, et al. (2013) A culture-independent sequence-based metagenomics approach to the investigation of an outbreak of Shiga-toxigenic Escherichia coli O104:H4. JAMA 309: 1502-1510.
9. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, et al. (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50: 1376-1383.
10. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
11. Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, et al. (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771-774.
12. Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, et al. (2011) Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 106: 630-642.
13. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623.
14. Lepage P, Hasler R, Spehlmann ME, Rehman A, Zvirbliene A, et al. (2011) Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141: 227-236.
15. Manichanh C, Borruel N, Casellas F, Guarner F, (2012) The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9: 599-608.
16. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
17. Gill N, Ferreira RB, Antunes LC, Willing BP, Sekirov I, et al. (2012) Neutrophil elastase alters the murine gut microbiota resulting in enhanced Salmonella colonization. PLoS ONE 7: e49646.
18. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 119-129.
19. Gorkiewicz G, Thallinger GG, Trajanoski S, Lackner S, Stocker G, et al. (2013) Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS ONE 8: e55817.
20. Dethlefsen L, Relman DA, (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108 (Suppl 1) (): 4554-4561.
21. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, et al. (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13: R79.
22. Carlsson AH, Yakymenko O, Olivier I, Hakansson F, Postma E, et al. (2013) Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol 48: 1136-1144.
23. de Vrieze J, (2013) Medical research. The promise of poop. Science 341: 954-957.
24. Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, et al. (2013) Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 19: 2155-2165.
25. Loman NJ, Constantinidou C, Chan JZ, Halachev M, Sergeant M, et al. (2012) High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol 10: 599-606.
26. Soergel DA, Dey N, Knight R, Brenner SE, (2012) Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME J 6: 1440-1444.
27. Muegge BD, Kuczynski J, Knights D, Clemente JC, Gonzalez A, et al. (2011) Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332: 970-974.
28. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214.
29. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, et al. (2010) Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A 107: 7503-7508.
30. Yang I, Nell S, Suerbaum S, (2013) Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 37: 736-761.
31. Fricke WF, Rasko DA, (2014) Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions. Nat Rev Genet 15: 49-55.
32. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, et al. (2011) Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 13: 47-58.
33. Ley RE, Turnbaugh PJ, Klein S, Gordon JI, (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
34. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236.
35. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, et al. (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14: 207-215.
36. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R, (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489: 220-230.